Company description
Dr. Changrui Xiao is a board-certified UCI Health neurologist, clinical geneticist and medical biochemical geneticist who specializes in neurogenetic and inherited metabolic disorders. His clinical interests include lysosomal storage diseases, hereditary and spinocerebellar ataxia, neurometabolic disorders, inborn errors of metabolism in adults, late onset Tay-Sachs and Sandhoff diseases, and genomic diagnosis. Xiao earned his medical degree at Duke University School of Medicine in Durham, N.C. He completed an internship in internal medicine and a residency in neurology at the University of Chicago Medical Center in Illinois. He received fellowship training in medical genetics and medical biochemical genetics at the National Institutes of Health Clinical Center and Johns Hopkins Hospital in Bethesda, Md., and Children's National Hospital in Washington, D.C. Before joining UCI Health, he was a clinician with the National Institutes of Health Undiagnosed Disease Program. He is the author or co-author of numerous peer-reviewed publications and presentations. He is an associate editor of the journal Molecular Genetics & Genomic Medicine and a consulting editor for GeneReviews. His goal is to provide a medical home for adults with neurogenetic and metabolic conditions, and to increase access to precision therapy for these conditions.
